Abstract | BACKGROUND: METHODS: We conducted an observational study on patients with sepsis admitted to intensive care unit (ICU) at a teaching hospital from January 2016 to December 2018. Levels of sTM, t-PAIC, TAT and PIC were measured at admission day and day 5-7 after admission and detected by qualitative chemiluminescence enzyme immunoassay performed on HISCL automated analyzers. RESULTS: A total of 179 septic patients and 125 non-septic ICU controls were enrolled. The level of sTM was higher in septic patients compared to ICU controls (OR =1.093, 95% CI: 1.045-1.151, P<0.001). Moreover, higher levels of sTM and t-PAIC were independent predictors of poor 60-day prognosis for septic patients (HR =1.012, 95% CI: 1.003-1.022, P=0.012; HR =1.014, P=0.009). Level of sTM was also higher in patients with septic shock as revealed by multivariate analysis (OR =1.049, 95% CI: 1.020-1.078, P=0.001), as well as in patients with sepsis-induced DIC (OR =1.109, 95% CI: 1.065-1.158, P<0.001). sTM was considered as a sensitive biomarker for the early prediction of septic shock and sepsis-induced DIC, with AUC up to 0.765 (0.687-0.842) and 0.864 (0.794-0.935) of receiver operating characteristic curve. CONCLUSIONS: Most patients developed coagulopathy which was closely linked to endothelial injury in initial phase of sepsis, which was demonstrated by abnormalities in endothelial biomarkers and their strong association with poor 60-day prognosis and development of septic shock and sepsis-induced DIC.
|
Authors | Jin Zhang, Mingming Xue, Yao Chen, Chenglong Liu, Zhongshu Kuang, Sucheng Mu, Wei Wei, Jun Yin, Hao Xiang, Yanyan Hu, Xiangyu Long, Shuo Fang, Si Sun, Beili Wang, Chaoyang Tong, Zhenju Song |
Journal | Annals of palliative medicine
(Ann Palliat Med)
Vol. 10
Issue 10
Pg. 10170-10184
(10 2021)
ISSN: 2224-5839 [Electronic] China |
PMID | 34551574
(Publication Type: Journal Article, Observational Study)
|
Chemical References |
- Biomarkers
- Plasminogen Inactivators
- Thrombomodulin
- Tissue Plasminogen Activator
|
Topics |
- Biomarkers
- Disseminated Intravascular Coagulation
(diagnosis, etiology)
- Humans
- Plasminogen Inactivators
- Prognosis
- Sepsis
(complications)
- Shock, Septic
(diagnosis)
- Thrombomodulin
(blood)
- Tissue Plasminogen Activator
(blood)
|